This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bryan, C. S.
Right arrow Articles by White, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bryan, C. S.
Right arrow Articles by White, W. L.

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1978 October; 14(4): 634-635
Copyright © 1978 American Society for Microbiology. All Rights Reserved.

Safety of Oral Vancomycin in Functionally Anephric Patients

Charles S. Bryan and Wain L. White

University of South Carolina School of Medicine and Richland Memorial Hospital, Columbia, South Carolina 29203

ABSTRACT

Administration of a vancomycin oral solution, 2 g daily for 16 days, to functionally anephric patients without inflammatory bowel disease resulted in assayable but low (≤0.66 µg/ml) serum levels in two of the five volunteers.


Antimicrob Agents Chemother. 1978 October; 14(4): 634-635
Copyright © 1978 American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Cadle, R. M, Mansouri, M. D, Darouiche, R. O (2006). Vancomycin-Induced Elevation of Liver Enzyme Levels. The Annals of Pharmacotherapy 40: 1186-1189 [Abstract] [Full Text]  
  • SPITZER, P. G., ELIOPOULOS, G. M. (1984). Systemic Absorption of Enteral Vancomycin in a Patient with Pseudomembranous Colitis. ANN INTERN MED 100: 533-534 [Abstract]